Twenty/Twenty Therapeutics
Other, 259 E Grand Ave, South San Francisco, California, 94080, United States, 51-200 Employees
Who is TWENTY/TWENTY THERAPEUTICS
Twenty Twenty Therapeutics is focused on harnessing the convergence of AI, microelectronics and scalable digital technologies with diagnostic and preventative eye care to bring innovative...
Read More
-
Headquarters: 259 E Grand Ave, South San Francisco, California, 94080, United States
-
Date Founded: 2020
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Other
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from TWENTY/TWENTY THERAPEUTICS
Twenty/Twenty Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Twenty::Twenty Therapeutics
Answer: Twenty/Twenty Therapeutics's headquarters are located at 259 E Grand Ave, South San Francisco, California, 94080, United States
Answer: Twenty/Twenty Therapeutics's official website is https://twentytwenty.com
Answer: Twenty/Twenty Therapeutics's revenue is $50 Million to $100 Million
Answer: Twenty/Twenty Therapeutics's SIC: 2834
Answer: Twenty/Twenty Therapeutics has 51-200 employees
Answer: Twenty/Twenty Therapeutics is in Other
Answer: Twenty/Twenty Therapeutics contact info: Phone number: Website: https://twentytwenty.com
Answer: Twenty Twenty Therapeutics is focused on harnessing the convergence of AI, microelectronics and scalable digital technologies with diagnostic and preventative eye care to bring innovative solutions for eye diseases to market. Our vision is to eliminate preventable blindness. By transforming the delivery of today's eye-care, we are improving patient access to intuitive and affordable diagnostics and treatments. We believe it should be easy for doctors to deliver superior outcomes to their patients. Our technology empowers patients to care for their own vision in between doctors visits. To accomplish these goals, we develop, market and commercialize transformative innovations in diagnostics, sensing, and preventative / medical / surgical treatments for eye diseases. We were formed in August 2020 as a joint venture between Verily Life Sciences, an Alphabet company, and Santen, a leading Japanese pharmaceutical company. We are passionate and committed to building and sustaining an inclusive and equitable working environment. Every member on our team enriches our diversity by exposing us to a broad range of views that help us understand and engage with the world, identify challenges, and to discover, design and deliver solutions. The Twenty Twenty work environment empowers our team to do their absolute best work.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month